The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Cognitive Impairment and the Brain Dopaminergic System in Parkinson Disease: [18F]Fluorodopa Positron Emission Tomographic Study
Abstract
OBJECTIVE: To investigate the role of the brain dopaminergic system in cognitive impairment in patients with Parkinson disease (PD). DESIGN: We studied 28 patients with PD and 16 age-matched healthy control subjects using [18F] fluorodopa (fluorodopa F 18) positron emission tomography. Patients with PD showed a variable degree of cognitive impairment, which was assessed using the Mini-Mental State Examination and detailed neuropsychologic assessment, including tests sensitive for frontal lobe function. RESULTS: [18F] Fluorodopa uptake was reduced in the putamen (to 36% of the control mean; P<.001), the caudate nucleus (to 61% of the control mean; P<.001), and the frontal cortex (to 45% of the control mean; P<.001) in patients with PD compared with controls. There was no significant association between the degree of overall cognitive impairment of patients and [18F] fluorodopa uptake values. The influx constant (Ki(occ)) in the caudate nucleus had a negative association with performance in the attention-demanding Stroop interference task, especially with the interference time. The Ki(occ) in the frontal cortex had a positive correlation with performance in the digit span (backwards), verbal fluency, and verbal immediate recall tests. Thus, the better the patient performed in tasks demanding immediate and working memory and executive strategies, the better the [18F] fluorodopa uptake in the frontal cortex. In the putamen, no significant correlation was seen between the Ki(occ) value and any of the cognitive tests. The severity of the motor symptoms of PD and [18F]fluorodopa uptake showed a negative correlation in the putamen (r = -0.38; P = .04), and in the caudate nucleus a similar trend was seen (r = -0.36; P = .06). CONCLUSIONS: Reduced [18F]fluorodopa uptake in PD in the caudate nucleus (and frontal cortex) is related to impairment in neuropsychologic tests measuring verbal fluency, working memory, and attentional functioning reflecting frontal lobe function. This indicates that dysfunction of the dopamine system has an impact on the cognitive impairment of patients with PD. However, our results do not exclude the possibility of more generalized cognitive impairment in PD, the pathophysiology of which is probably different and more generalized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
The Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
The behavioural and motor consequences of focal lesions of the basal ganglia in man
Bhatia, K. P., & Marsden, C. D. (1994) · Brain · doi:10.1093/brain/117.4.859 · Cited by 1,073
FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE: THE CORTICAL FOCUS OF NEOSTRIATAL OUTFLOW
TAYLOR, A. E., SAINT-CYR, J. A., & LANG, A. E. (1986) · Brain · doi:10.1093/brain/109.5.845 · Cited by 882
‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
COGNITIVE DEFICITS IN THE EARLY STAGES OF PARKINSON'S DISEASE
LEES, A. J., & SMITH, E. (1983) · Brain · doi:10.1093/brain/106.2.257 · Cited by 790
Recent Advances in the Molecular Biology of Dopamine Receptors
Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 779
Scatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90993-9 · Cited by 726
COOPER, J. A., SAGAR, H. J., JORDAN, N., HARVEY, N. S., & SULLIVAN, E. V. (1991) · Brain · doi:10.1093/brain/114.5.2095 · Cited by 627
Lange, K. W., Robbins, T. W., Marsden, C. D., James, M., Owen, A. M., & Paul, G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245167 · Cited by 610
Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates
Berger, B., Gaspar, P., & Verney, C. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90179-x · Cited by 588
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Seibyl, J. P., Marchek, K. L., Quinlan, D., Sheff, K., Zoghbi, S., Zea‐Ponce, Y., Baldwin, R. M., Fussell, B., Smith, E. O., Charney, D. S., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380407 · Cited by 467
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
Rinne, J. O., Mlic, J. R., Paljärvi, L., & Rinne, U. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260107 · Cited by 331
Self-citationExplicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases
Pillon, B., Deweer, B., Agid, Y., & Dubois, B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040036010 · Cited by 316
Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology
Cummings, J. L. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.682 · Cited by 300
Pillon, B., Dubois, B., Lhermitte, F., & Agid, Y. (1986) · Neurology · doi:10.1212/wnl.36.9.1179 · Cited by 292
Robbins, T. W., James, M., Owen, A. M., Lange, K. W., Lees, A. J., Leigh, P. N., Marsden, C. D., Quinn, N. P., & Summers, B. A. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.1.79 · Cited by 272
BROOKS, D. J., SALMON, E. P., MATHIAS, C. J., QUINN, N., LEENDERS, K. L., BANNISTER, R., MARSDEN, C. D., & FRACKOWIAK, R. S. J. (1990) · Brain · doi:10.1093/brain/113.5.1539 · Cited by 256
Namavari, M., Bishop, A., Satyamurthy, N., Bida, G., & Barrio, J. R. (1992) · International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes · doi:10.1016/0883-2889(92)90217-3 · Cited by 223
Eidelberg, D., Moeller, J. R., Dhawan, V., Sidtis, J. J., Ginos, J. Z., Strother, S. C., Cedarbaum, J., Greene, P., Fahn, S., & Rottenberg, D. A. (1990) · Movement Disorders · doi:10.1002/mds.870050304 · Cited by 204
Parkinson's disease in twins studied with 18 F‐dopa and positron emission tomography
Burn, D. J., Mark, M. H., Playford, E. D., Maraganore, D. M., Zimmerman, T. R., Duvoisin, R. C., Harding, A. E., Marsden, C. D., & Brooks, D. J. (1992) · Neurology · doi:10.1212/wnl.42.10.1894 · Cited by 197
Kujala, P., Portin, R. I., Revonsuo, A., & Ruutiainen, J. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.1.77 · Cited by 188
Self-citationGaspar, P., Stepniewska, I., & Kaas, J. H. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903250102 · Cited by 182
Ishikawa, T., DHAWAN, V. M., Kazumata, K., Chaly, T., Mandel, F. S., Neumeyer, J. L., Margouleff, C., Babchyck, B., ZANZI, I., & Eidelberg, D. (1996) · PubMed · Cited by 165
Intellectual changes in patients with MPTP‐induced parkinsonism
Stern, Y., & Langston, J. W. (1985) · Neurology · doi:10.1212/wnl.35.10.1506 · Cited by 149
Cognitive change following MPTP exposure
Stern, Y., Tetrud, J. W., Martin, W. R. W., Kutner, S. J., & Langston, J. W. (1990) · Neurology · doi:10.1212/wnl.40.2.261 · Cited by 146
Holthoff‐Detto, V., Vieregge, P., Kessler, J., Pietrzyk, U., Herholz, K., Bonner, J. A., Wagner, R. L., Wienhard, K., Pawlik, G., & Heiss, W. (1994) · Annals of Neurology · doi:10.1002/ana.410360209 · Cited by 108
Functional Effects of Striatal Dysfunction in Parkinson Disease
Holthoff‐Detto, V., Kessler, J., Herholz, K., Bönner, H., Pietrzyk, U., Würker, M., Ghaemi, M., Wienhard, K., Wagner, R. L., & Heiss, W. ‐. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550140025008 · Cited by 104
Cognitive performance in early Parkinson's disease
Hietanen, M., & Teräväinen, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb03257.x · Cited by 100
L-dopa and frontal cognitive function in Parkinson's disease.
Lange, K. W., Paul, G. M., Robbins, T. W., & MARSDEN, C. D. (1993) · PubMed · Cited by 81
Slowing of Information Processing in Parkinson′s Disease
Revonsuo, A., Portin, R. I., Koivikko, L., Rinne, J. O., & Rinne, U. K. (1993) · Brain and Cognition · doi:10.1006/brcg.1993.1007 · Cited by 66
Self-citationRinne, J. O., Kuikka, J. T., Bergström, K., & Rinne, U. K. (1995) · Parkinsonism & Related Disorders · doi:10.1016/1353-8020(95)00012-u · Cited by 48
Self-citationDetermination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert, M., Koeppe, R. A., Giordani, B., Minoshima, S., & Kuhl, D. E. (1996) · PubMed · Cited by 42
PET and the investigation of dementia in the parkinsonian patient
Turjanski, N., & Brooks, D. J. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_4 · Cited by 23
Positron emission tomography in degenerative disorders of the dopaminergic system
Karbe, H., Holthoff‐Detto, V., Huber, M., Herholz, K., Wienhard, K., Wagner, R. L., & Heiss, W. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251475 · Cited by 23
Cited by
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131
“More recent studies confirmed previous data and showed positive correlations between a decline in dopaminergic activity with age and alterations of cognitive function (Rinne et al., 2000).”
ResultThe cognitive functions of the caudate nucleus
Grahn, J. A., Parkinson, J. A., & Owen, A. M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.004 · Cited by 940
Metadata
- Authors
- Rinne, J. O., Portin, R., Ruottinen, H., Nurmi, E., Bergman, J., Haaparanta, M., & Solin, O.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2000-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 470
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2045180389
- Cited by
- 337
- References
- 43
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.